Showing results (1381-1390 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|June 27, 2006
In vitro and direct in vivo testing of mixture-based combinatorial libraries for the identification of highly active and specific opiate ligandsRichard A Houghten, Colette T Dooley, Jon R AppelThe AAPS Journal|June 27, 2006
Discovery pharmaceutics--challenges and opportunitiesXue-Qing Chen, Melissa D Antman, Christoph Gesenberg, et al.The AAPS Journal|December 9, 2022
Overcoming Biopharmaceutical Interferents for Quantitation of Host Cell DNA Using an Automated, High-Throughput MethodologyMackenzie L Lauro, Amy M Bowman, Joseph P Smith, et al.The AAPS Journal|January 11, 2019
What Does it Take to Make Model-Informed Precision Dosing Common Practice? Report from the 1st Asian Symposium on Precision DosingThomas M Polasek, Amin Rostami-Hodjegan, Dong-Seok Yim, et al.The AAPS Journal|November 3, 2019
Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life CycleRoman Mathaes, Linda Narhi, Andrea Hawe, et al.The AAPS Journal|January 5, 2021
Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out ApproachXavier J H Pepin, James E Huckle, Ravindra V Alluri, et al.The AAPS Journal|July 29, 2021
An Integrated Analysis of Dostarlimab ImmunogenicitySharon Lu, Ronald R Bowsher, Amanda Clancy, et al.The AAPS Journal|April 17, 2013
Factors influencing magnitude and duration of target inhibition following antibody therapy: implications in drug discovery and developmentAnjaneya P Chimalakonda, Rajbharan Yadav, Punit MaratheThe AAPS Journal|April 17, 2013
Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancerHarold Ting, Gagan Deep, Rajesh AgarwalThe AAPS Journal|April 18, 2013
Protective effects of kaempferol on isoniazid- and rifampicin-induced hepatotoxicityTung-Yuan Shih, Ton-Ho Young, Herng-Sheng Lee, et al.Pageof 235